Trials / Conditions / FGFR2 Gene Translocation

FGFR2 Gene Translocation

4 registered clinical trials studyying FGFR2 Gene Translocation.

Status	Trial	Sponsor	Phase
Terminated	Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 Fusion/Rearrangements NCT05565794	Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest	Phase 2
Unknown	Real Word European Registry of NTRK Fusions and Other Rare Actionable Fusions (TRacKING) NCT04921553	Centre Leon Berard	—
Completed	REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other NCT04526106	Elevar Therapeutics	Phase 1 / Phase 2
Unknown	Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations NCT04096417	Academic and Community Cancer Research United	Phase 2